Otsu, Japan

Yuki Sugahara

This inventor holds 1 USPTO granted patent. Top assignee: Takara Shuzo Co., Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuki Sugahara. Retrieved from https://idiyas.com/inventor/yuki-sugahara-vm2esjms

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuki Sugahara: Innovator in Polypeptide Technology

Introduction

Yuki Sugahara is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with unique properties. His work has implications for various applications in medicine and research.

Latest Patents

Yuki Sugahara holds a patent for a polypeptide with cell-spreading activity. This polypeptide exhibits the cell-spreading activity of human fibronectin, which is crucial for cell adhesion and migration. The methods of preparing this polypeptide are also described in his patent, showcasing his innovative approach to biotechnology.

Career Highlights

Sugahara is associated with Takara Shuzo Co., Inc., a company known for its advancements in life sciences and biotechnology. His role at the company has allowed him to focus on research and development, contributing to the advancement of scientific knowledge and technology.

Collaborations

Yuki Sugahara has collaborated with notable colleagues, including Yoh'ichi Ohdate and Tatsuru Kinoshita. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Yuki Sugahara's contributions to the field of biotechnology, particularly through his patented polypeptide, highlight his role as an innovator. His work continues to influence research and applications in cell biology and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…